Search

Aadel Chaudhuri Phones & Addresses

  • Palo Alto, CA
  • 954 Little Valley Rd, Salt Lake City, UT 84103 (801) 243-4477
  • Chesterfield, MO
  • Saint Louis, MO
  • San Diego, CA
  • Santa Clara, CA
  • Menlo Park, CA
  • Pasadena, CA
  • Herndon, VA
  • 954 N Little Valley Rd, Salt Lake Cty, UT 84103

Work

Company: Guidepoint Jun 2020 Position: Healthcare consultant

Education

Degree: Doctor of Medicine, Doctorates School / High School: Stanford University School of Medicine 2004 to 2013 Specialities: Medicine

Skills

Cancer Genomics • Cancer Treatment • Cancer Research • Translational Research • Clinical Research • Molecular Biology • Direct Patient Care • Dna Sequencing • Biomarkers • Bioinformatics • Dna • Laboratory Skills • Rna • Research • Biostatistics

Industries

Hospital & Health Care

Resumes

Resumes

Aadel Chaudhuri Photo 1

Healthcare Consultant

View page
Location:
Palo Alto, CA
Industry:
Hospital & Health Care
Work:
Guidepoint
Healthcare Consultant

Roche
Advisor

Tempus, Inc.
Consultant

Washington University In St. Louis
Assistant Professor, Computer Science

Geneoscopy
Advisor
Education:
Stanford University School of Medicine 2004 - 2013
Doctor of Medicine, Doctorates, Medicine
Caltech 2007 - 2011
Doctorates, Doctor of Philosophy, Biology, Philosophy
Massachusetts Institute of Technology 2000 - 2004
Bachelors, Electrical Engineering, Biology, Computer Science
Skills:
Cancer Genomics
Cancer Treatment
Cancer Research
Translational Research
Clinical Research
Molecular Biology
Direct Patient Care
Dna Sequencing
Biomarkers
Bioinformatics
Dna
Laboratory Skills
Rna
Research
Biostatistics

Publications

Us Patents

Regulation Of Macrophage Activation Using Mir-125B

View page
US Patent:
20120322854, Dec 20, 2012
Filed:
Jun 18, 2012
Appl. No.:
13/526347
Inventors:
Aadel Chaudhuri - Santa Clara CA, US
Alex Steven So - Los Angeles CA, US
David Baltimore - Pasadena CA, US
Ryan M. O'Connell - Salt Lake City UT, US
Assignee:
CALIFORNIA INSTITUTE OF TECHNOLOGY - Pasadena CA
International Classification:
A61K 31/7088
A61P 1/00
A61P 19/02
A61P 25/00
US Classification:
514 44 A
Abstract:
The present disclosure relates to regulation of macrophage activation by delivering of miRNAs, for example miR-125or anti-miR-125, to macrophages. For example, in some embodiments, macrophage activation can be elevated or reduced by administering miR-125or anti-miR-125oligonucleotides. Also disclosed are methods for promoting T cell activation and method for treating various disorders such as tumor and autoimmune diseases.

Methods For Cancer Treatment

View page
US Patent:
20230127134, Apr 27, 2023
Filed:
Dec 22, 2022
Appl. No.:
18/087165
Inventors:
- Melrose MA, US
Aadel Chaudhuri - Chesterfield MO, US
Stanley N. Lapidus - Golden CO, US
International Classification:
A61M 27/00
Abstract:
The present invention relates to novel surgical drains and associated methods and systems. Specifically, the present invention includes a surgical drain with at least two ports. A first port drains lymphatic fluid from a subject for collection and analysis. The second port functions to introduce a therapeutic into the subject.

Methods For Disease Assessment Using Drain Fluid

View page
US Patent:
20230131016, Apr 27, 2023
Filed:
Dec 22, 2022
Appl. No.:
18/087148
Inventors:
- Melrose MA, US
Aadel Chaudhuri - Chesterfield MO, US
Stanley N. Lapidus - Golden CO, US
Theresa Tribble - Melrose MA, US
International Classification:
C12Q 1/6886
Abstract:
The present invention provides methods for using surgical drainage waste fluid as a means for diagnosing disease, assessing disease progression, predicting metastatic disease, assessing cancer metastasis, disease staging, molecular staging, and assessing metastatic disease. During surgery, suction is used to drain fluids such as blood, tissue fluids, and other bodily fluids away from the surgery site. The suction drainage fluid waste, also called drain fluid, is removed from the patient during the surgical procedure. Because surgical drain fluid is typically viewed as something that is not useful, it is disregarded and thrown away during the surgery. Instead, the invention provides that drain fluid, which is mostly lymphatic fluid and interstitial fluid, is diagnostically rich and contains important information for assessing, diagnosing, and treating disease. The methods of the invention use this waste fluid for the valuable data it contains. Therefore, while a patient is already undergoing surgery for a medical condition, the waste drain fluid is sampled and analyzed for biomarkers or other molecular indicia of disease.

Drain Fluid For Diagnostics

View page
US Patent:
20230092038, Mar 23, 2023
Filed:
Sep 30, 2021
Appl. No.:
17/491237
Inventors:
- Melrose MA, US
Aadel Chaudhuri - Chesterfield MO, US
Stanley N. Lapidus - Golden CO, US
International Classification:
C12Q 1/6886
Abstract:
The present invention provides methods for testing surgical fluid for biomarkers of disease, including cancer.
Aadel A Chaudhuri from Palo Alto, CA, age ~42 Get Report